At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Saphenous vein graft (SVG) stentingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Marketing Surveillance (PMS) Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention
In Brief
An observational study evaluating Saphenous vein graft (SVG) stenting for Stenosis. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The objective of this study is to collect data on the use of the WIRION system in Patients undergoing Percutaneous Intervention of Saphenous Vein Graft (SVG).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStenosis
CountriesIsrael
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedFeb 2015
Primary CompletionMay 2015
Study CompletionJun 2016
TodayJul 2026
First PostedFeb 27, 2015
Enrollment StartOct 1, 2014
Primary CompletionMay 1, 2015
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.3 years ago
Interventions
Saphenous vein graft (SVG) stentingdevice
Opening and stenting of blocked SVG with the use of the WIRION embolic protection filter